Literature DB >> 8304053

Macrophage colony-stimulating factor release and receptor expression in bone cells.

E C Weir1, M C Horowitz, R Baron, M Centrella, B M Kacinski, K L Insogna.   

Abstract

Colony-stimulating factors (CSF) may play a role in bone resorption. To examine whether osteoblasts secrete colony-stimulating activity (CSA) in response to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP), conditioned medium (CM) from ROS 17/2.8 cells and primary rat osteoblasts were examined for induction of clonal growth of cultured rat bone marrow cells. Untreated cells constitutively secreted CSA, which increased with PTH and PTHrP treatment. The colonies formed were principally comprised of macrophages, and preincubation of CM with antiserum to murine macrophage colony-stimulating factor (M-CSF) neutralized most of the CSA, suggesting that the osteoblast-derived CSA was predominantly due to M-CSF. PTHrP treatment upregulated steady-state M-CSF mRNA levels. To investigate a paracrine role for M-CSF in bone we examined bone tissue and cells for the M-CSF receptor c-fms using immunohistochemical techniques and demonstrated staining of mature osteoclasts both in situ and after isolation. We conclude that M-CSF is responsible for the majority of the CSA released by PTH- and PTHrP-treated rat osteoblasts. In addition we identified CSF-1 receptor expression in mature osteoclasts. These data suggest that M-CSF is a mediator of osteoblast-osteoclast interaction in PTH- and PTHrP-induced bone resorption.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8304053     DOI: 10.1002/jbmr.5650081214

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  24 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 3.  Cytokines in the pathogenesis of osteoporosis.

Authors:  E Romas; T J Martin
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 4.  Circulating monocytes: an appropriate model for bone-related study.

Authors:  Y Zhou; H-W Deng; H Shen
Journal:  Osteoporos Int       Date:  2015-07-21       Impact factor: 4.507

Review 5.  Macrophages and skeletal health.

Authors:  Megan N Michalski; Laurie K McCauley
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 6.  Recent developments in metabolic bone diseases: a gnathic perspective.

Authors:  Erich J Raubenheimer; Claudia E Noffke; Hilde D Hendrik
Journal:  Head Neck Pathol       Date:  2014-11-20

7.  Identification of a 22 bp DNA cis Element that Plays a Critical Role in Colony Stimulating Factor 1-Dependent Transcriptional Activation of the SPHK1 Gene.

Authors:  Gang Qing Yao; Meiling Zhu; Joanne Walker; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2020-04-03       Impact factor: 4.333

8.  Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation.

Authors:  E C Weir; W M Philbrick; M Amling; L A Neff; R Baron; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

9.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23

10.  Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.

Authors:  K L Insogna; M Sahni; A B Grey; S Tanaka; W C Horne; L Neff; M Mitnick; J B Levy; R Baron
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.